Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,597 | 2,536 | 1,624 | 1,703 | 1,350 |
| Cost of Goods | 461 | 1,420 | 615 | 1,015 | 173 |
| Gross Profit | 1,136 | 1,116 | 1,009 | 688 | 1,177 |
| Operating Expenses | 4,221 | 3,594 | 3,754 | 2,941 | 4,542 |
| Operating Income | -2,624 | -2,059 | -2,130 | -2,238 | -3,191 |
| Interest Expense | 90 | 93 | 83 | 71 | 56 |
| Other Income | -113 | 610 | 4,028 | 143 | 60 |
| Pre-tax Income | -2,827 | -1,542 | 1,815 | -2,166 | -3,188 |
| Income Tax | 3 | -1,051 | N/A | 3 | 0 |
| Net Income Continuous | -2,829 | -490 | 1,815 | -2,169 | -3,188 |
| Net Income | $-2,829 | $-490 | $1,815 | $-2,169 | $-3,188 |
| EBITDA(a) | $-2,335 | $-1,765 | $-1,905 | $-2,050 | $-2,982 |